Increased Mortality Among Persons With Symptomatic Coronavirus Disease 2019 (COVID-19) During the Period of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) B.1.617.2 (Delta Variant) Predominance: Alaska, November 2020-October 2021.

Mooring, Eric Q; Newell, Katherine; Castrodale, Louisa; Tompkins, Megan; Frank, Morgan; McLaughlin, Joseph

Mooring, Eric Q; Newell, Katherine; Castrodale, Louisa; Tompkins, Megan; Frank, Morgan; McLaughlin, Joseph.

Afiliación

Mooring EQ; CDC COVID-19 Response, Anchorage, Alaska, USA.
Newell K; CDC COVID-19 Response, Anchorage, Alaska, USA.
Castrodale L; Epidemic Intelligence Service Officer, Anchorage, Alaska, USA.
Tompkins M; Alaska Division of Public Health, Section of Epidemiology, Anchorage, Alaska, USA.
Frank M; Alaska Division of Public Health, Section of Epidemiology, Anchorage, Alaska, USA.
McLaughlin J; Alaska Division of Public Health, Section of Epidemiology, Anchorage, Alaska, USA.

Clin Infect Dis ; 75(Suppl 2): S298-S302, 2022 10 03.

Article en En | MEDLINE | ID: mdl-35767294

Asunto(s)

COVID-19; SARS-CoV-2; Alaska/epidemiología; Humanos

Palabras clave

B.1.617.2 (Delta); SARS-CoV-2; mortality; vaccination; virulence

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Diagnostic_studies Límite: Humans País/Región como asunto: America do norte Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google